N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141395 |
| CAS No | NA |
| Mol.F. | C9H10BrClN4O |
| Mol.Wt. | 305.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141396 |
| CAS No | NA |
| Mol.F. | C12H13ClN4O2 |
| Mol.Wt. | 280.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141397 |
| CAS No | NA |
| Mol.F. | C28H37N9O4 |
| Mol.Wt. | 563.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141398 |
| CAS No | NA |
| Mol.F. | C27H33N9O5 |
| Mol.Wt. | 563.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141399 |
| CAS No | NA |
| Mol.F. | C9H13N5O |
| Mol.Wt. | 207.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141400 |
| CAS No | NA |
| Mol.F. | C16H12N4O4 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141401 |
| CAS No | NA |
| Mol.F. | C17H13N3O4 |
| Mol.Wt. | 323.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141402 |
| CAS No | NA |
| Mol.F. | C14H12N2O2 |
| Mol.Wt. | 240.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141403 |
| CAS No | NA |
| Mol.F. | C29H20N4O3 |
| Mol.Wt. | 472.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141404 |
| CAS No | NA |
| Mol.F. | C23H23BrN4O4 |
| Mol.Wt. | 499.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141405 |
| CAS No | NA |
| Mol.F. | C23H23BrN4O4 |
| Mol.Wt. | 499.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141406 |
| CAS No | NA |
| Mol.F. | C9H7N3O4 |
| Mol.Wt. | 221.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141407 |
| CAS No | NA |
| Mol.F. | C11H12N4O3 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141408 |
| CAS No | NA |
| Mol.F. | C16H13N3O4 |
| Mol.Wt. | 311.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141409 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141410 |
| CAS No | NA |
| Mol.F. | C11H12N4O3 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |